Catalyst Wire Dossier Catalyst Wire Dossier

VIDAZA

AZACITIDINE · Celgene Corporation
Drug timelines are a Plus or Pro feature.

127 regulatory and trial events tracked for VIDAZA, covering 2007-01-26 to 2026-04-24. Get the full timeline:

Most recent: Clinical Trial Update: Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial) [Phase 2]

See pricing